Opinion - Page 4

WASHINGTON — Earlier this month at a private event, Robert F. Kennedy Jr. and other top federal health officials announced a new National Institutes of Health center that would focus on patients with

Since five members of the American Diabetes Association were ejected from its scientific session in New Orleans on June 5, the professional organization has released two explanations, one apology, one summary of

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. As I pondered potential Halloween costumes, I was particularly tickled by an Instagram influencer

NATIONAL HARBOR, Md. — Hundreds of people responsible for 73 million Americans’ health care quieted as conference room lights dimmed and Mehmet Oz’s face appeared on giant screens Thursday morning. The Centers

The approval of daraxonrasib, a new life-extending drug for pancreatic cancer, is the biggest advance in decades against a notoriously hard-to-treat disease. But data readouts don’t show what those extra months mean

When Janet Freeman-Daily, a former aerospace engineer and self proclaimed “science geek,” was diagnosed with lung cancer, she made it her mission to learn about her disease.  Her curious nature eventually led

An experimental Huntington’s drug from Alnylam Pharmaceuticals showed promise in a small study, the company said Friday, suggesting it can partially silence the mutant gene that drives the devastating neurological disorder. Patients

More than 80 nutrition researchers and experts are calling on the White House to release the federal government’s proposed definition of ultra-processed foods, after its unveiling in August was canceled at the

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Speaking

It’s getting harder to dodge “You Can See Everything” spoilers, but you know what I’ll never dodge? STAT’s award-winning journalism. Speaking of, today’s newsletter features two stories from the illustrious Tara Bannow,